CCDM Risk-Based Monitoring 2

Question 1

What does 'targeted source data verification' (targeted SDV) mean in a risk-based monitoring plan?

Accepted Answer

Selecting specific critical data fields or subject records for SDV based on risk assessment rather than checking all data

Answer

Verifying only data from the top-enrolling clinical sites

Answer

Reviewing 100% of data fields for a randomly selected subset of subjects

Answer

Limiting SDV to safety data only and skipping efficacy data

Question 2

According to ICH E6(R2), which entity is primarily responsible for implementing a quality management system for a clinical trial?

Accepted Answer

The sponsor

Answer

The Institutional Review Board (IRB)

Answer

The contract research organization (CRO) if one is used

Answer

The principal investigator at each site

Question 3

In risk-based monitoring, what is the purpose of establishing a risk threshold for a KRI?

Accepted Answer

To define the point at which a KRI value triggers a predefined escalation or investigation action

Answer

To set the maximum number of protocol deviations allowed before a site is closed

Answer

To determine the minimum number of on-site visits required per year

Answer

To calculate the overall budget for monitoring activities

Question 4

Which statistical technique is commonly used in centralized monitoring to identify sites that are statistical outliers compared to the overall study population?

Accepted Answer

Z-score and interquartile range (IQR) analysis

Answer

Kaplan-Meier survival analysis

Answer

ANCOVA for treatment effect estimation

Answer

Chi-square test for primary endpoint analysis

Question 5

What action should a clinical data manager take when a KRI exceeds its predefined threshold during centralized monitoring review?

Accepted Answer

Escalate findings per the monitoring plan, which may include contacting the site and documenting the signal

Answer

Immediately lock the database for that site

Answer

Remove the site's data from the final analysis

Answer

Wait until the next scheduled monitoring visit to investigate

Question 6

Which component must be included in a risk-based monitoring plan to satisfy ICH E6(R2) requirements?

Accepted Answer

Documentation of the risk assessment that informed the monitoring strategy, including identified risks and mitigations

Answer

A complete list of all FDA-approved software platforms used at each site

Answer

Signatures from all site investigators confirming they understand the monitoring approach

Answer

A guarantee that no protocol deviations will occur during the study

Question 7

Which of the following best describes a 'critical data' element in the context of risk-based monitoring?

Accepted Answer

Data that directly affects subject safety determinations or the primary efficacy analysis

Answer

Any data field that is collected more than once per visit

Answer

Data collected from the highest-enrolling sites only

Answer

Electronic data capture fields that require double-data entry